“Apellis Pharmaceuticals: Key Relative Strength Update”

Avatar photo

Buffett’s Wisdom: Navigating Market Fear with APLS

Warren Buffett famously advises investors to adopt a cautious approach when others are overly optimistic and to seize opportunities when fear dominates the market. An effective tool to gauge this sentiment is the Relative Strength Index (RSI), a technical analysis metric that ranges from 0 to 100. When a stock’s RSI falls below 30, it is considered oversold, indicating potential buying opportunities.

On Monday, Apellis Pharmaceuticals Inc (Symbol: APLS) saw its RSI plunge into oversold territory at 27.5, with shares trading as low as $27.07. In contrast, the S&P 500 ETF (SPY) currently has an RSI of 64.3. For bullish investors, APLS’s low RSI suggests that the intense selling pressure may be waning, providing a possible entry point for future purchases. Below is the performance chart for APLS over the past year:

Apellis Pharmaceuticals Inc 1 Year Performance Chart

Reviewing the performance chart, APLS’s 52-week low stands at $26.28 per share, while its high reaches $73.80. This indicates the stock is currently trading near the lower end of its range, with the last trade recorded at $27.04.

Discover 9 other oversold stocks you need to watch »

Further Reading:
  • Paul Singer Stock Picks
  • Top Ten Hedge Funds Holding KIM
  • DENN Historical PE Ratio

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.

The free Daily Market Overview 250k traders and investors are reading

Read Now